Abstract:Importance: Nasal continuous positive airway pressure (NCPAP) as a primary respiratory therapy in meconium aspiration syndrome (MAS) has not been studied extensively. Nasal continuous positive airway pressure, when applied in newborns with MAS, may resolve atelectasis by sufficiently expanding partially obstructed small airways and stabilizing the collapsing terminal airways to enhance oxygen exchange. Objective: To compare NCPAP vs standard care in neonates with moderate to severe respiratory failure due to MAS in reducing the need for invasive ventilation. Design, settings, and participants: This multicenter open-label, parallel-group (1:1 ratio) randomized clinical trial was conducted from August 5, 2014, to May 26, 2016. Data were collected from 3 tertiary care neonatal intensive care units. All infants admitted with respiratory distress, defined as Downe score greater than 4 and peripheral capillary oxygen saturation less than 90%, were assessed for study eligibility if the chest radiograph was suggestive of MAS and they met the other inclusion criteria: gestation longer than 35 weeks, a birth weight greater than 2000 g, and born through meconium-stained amniotic fluid. Interventions: Infants were randomly assigned to either NCPAP or standard care (5-10 L/min hood oxygen). Main outcomes and measures: The primary outcome was the need for mechanical ventilation in the first 7 days of life. Results: After excluding 14 infants, 67 infants were randomized to bubble NCPAP and 68 infants to standard care. Baseline characteristics were similar between the 2 groups. Infants randomized to the bubble NCPAP group needed mechanical ventilation less frequently in the first 7 days of life compared with standard care (2 [3.0%] vs 17 [25.0%]); odds ratio, 0.09; 95% CI, 0.02-0.43; P = .002). The need for surfactant (3 [4.5%] vs 11 [16.2%]; odds ratio, 0.24; 95% CI, 0.05-0.87) and culture-positive sepsis (4 [6.0%] vs 13 [19.0%]; odds ratio, 0.28; 95% CI, 0.09-0.93) were higher in the standard care group. There was an increased duration of oxygen therapy (median [interquartile range], 45.5 [28.0-78.3] vs 26 [20.0-48.0] hours; P = .001) in the standard care group. In the NCPAP group vs standard care group, incidence of persistent pulmonary hypertension (9 [13%] vs 19 [28%]; odds ratio, 0.42; 95% CI, 0.17-1.01) and duration of hospital stay (median [interquartile range], 5.0 [4.0-8.8] vs 4.0 [4.0-6.0] days; P = .14) were similar. Conclusions and relevance: Bubble NCPAP in comparison with standard care for infants with MAS reduces the need for mechanical ventilation in the first 7 days of life. Trial registration: Clinical Trial Registry, India Identifier: CTRI/2015/03/005631.

Using nasal continous postive airway pressure treat 23 hyaline membrance disease of newborns.

A Prospective Randomizedcontrolled Trial of Synchronized Nasal Intermittent Positive Pressure Ventilation Intreatment of Hyaline Membrane Disease in Premature Infants

The use of noninvasive ventilation in the treatment of acute cardiogenic pulmonary edema

Comparison of clinical curative effects between NCPAP and CMV treatment on neonatal respiratory distress syndrome( NRDS)

Diagnosis and differential diagnosis of neonatal continuous pulmonary hypertension

Application of Nasal Continuous Positive Airway Pressure in Very Low Birth Weight Infants with Respiratory Distress

Nasal continuous positive airway pressure versus pulmonary surfactant in prevention of neonatal respiratory distress syndrome

[For or against the early use of nasal continuous positive pressure and exogenous surfactant in hyaline membrane disease. Physiopathologic arguments]

Influence of Nasal Continues Positive Airway Pressure on Retention of Carbon Dioxide in Newborn

Risk factors on the occurrence and prognosis of neonatal hyaline membrane disease]

Nasal continuous positive airway pressure treat obstructive sleep apnea syndrome

High-Flow Nasal Cannula vs. Continuous Positive Airway Pressure Therapy for the Treatment of Children <2 Years With Mild to Moderate Respiratory Failure Due to Pneumonia

Analysis on the high risk factors of pathogenesis and prognosis with hyaline membrane disease in premature infant

Application of biphasic positive airway pressure mechanical ventilation in neonatal respiratory failure

Effect of Nasal Continuous Positive Airway Pressure on Infants With Meconium Aspiration Syndrome: A Randomized Clinical Trial

Clinical analysis on mechanical ventilation combined with inhaled nitric oxide in the treat-ment of persistent pulmonary hypertension of newborn

Nasal Bi‐level Positive Airway Pressure (bipap) Versus Nasal Continuous Positive Airway Pressure (CPAP) in Preterm Infants ≤32 Weeks: A Retrospective Cohort Study

Congenital Diaphragmatic Hernia in Infants Treated with Permissive Hypercapnea

Treatment of Severe Cardiogenic Pulmonary Edema with Continuous Positive Airway Pressure by Nasal Face Mask

Feasibility and safety of weaning premature infants from nasal continuous positive airway pressure to high-flow nasal cannula: a prospective observational case study

Application of open lung strategy in mechanical ventilation treatment of neonatal respiratory distress syndrom